References
- Tatemoto K, Efendic S, Mutt V, Makk G, Feistner G J, Barchas JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476–8
- Efendic S, Tatemoto K, Mutt V, Quan C, Chang D, Ostenson CG. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987; 84: 7257–60
- Ahren B, Lindskog S, Tatemoto K, Efendic S. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988; 37: 281–5
- Flood J F, Morley J E, Tatemoto K. Effects of systemic pancreastatin on memory retention. Peptides 1988; 9: 1077–80
- Gunion M W, Rosenthal M J, Tatemoto K, Morley JE. Intracraniel microinfusion of pancreastatin elevates blood glucose, free fatty acids, and corti-costerone in rats. Brain Res 1989; 485: 251–7
- Funakoshi A, Miyasaka K, Nakamura R, Miyasaka K, Nakamura R, Kitani K, Tatemoto K. Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat. Regul Pept 1989; 25: 157–66
- Lewis J J, Goldenring J R, Asher V A, Modlin IM. Pancreastatin: a novel peptide inhibitor of parietal cell signal transduction. Biochem Biophys Res Commun 1989; 163: 667–73
- Fasciotto B H, Gott S U, De Franco D J, Levine M A, Cohn DV. Pancreastatin, a presumed production of chromogranin-A (secretory protein-I) processing inhibits secretion from porcine parathyroid cells in culture. Endocrinology 1989; 125: 1617–22
- Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Fujii N, Funakoshi S. The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion. FEBS Lett 1990; 263: 279–80
- Iacangelo A L, Fischer-Colbrie R, Koller K J, Brownstein M J, Eiden LE. The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 1988; 122: 2339–41
- O'Connor D T, Burton D, Deftos LJ. Immuno-reactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocr Metab 1983; 57: 1984–6
- O'Connor D T, Frigon RP. Chromogranin A, the major catecholamine storage vesicle soluble protein. J Biol Chem 1984; 259: 3237–47
- Wilson B S, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Path 1984; 115: 458–68
- Somogyi P, Hodgson A J, De Potter R W, Fischer-Colbrie R, Schober M, Winkler H, Chubb IW. Chromogranin immunoreactivity in the central nervous system. Immunochemical characterization, distribution and relationship to catecholamine and enkephalin pathways. Brain Res Rev 1984; 8: 193–230
- Itoh H, Hashimoto Y, Kitagawa H, Kon Y, Kudo N. Distribution of chromogranin containing cells in the porcine gastroenteropancreatic endocrine system. Jpn J Vet Sci 1988; 50: 395–404
- Shimizu F, Ikei N, Iwanaga T, Fujita T. An immunochemical and immunohistochemical study on pancreastatin-like immunoreactivity using synthetic peptides. Biomed Res 1987; 8: 457–62
- Bretherton-Watt D, Ghatei M A, Bishop A E, Facer P, Fahey M, Hedges M, Williams G, Valentino K, Tatemoto K, Roth K, Polak J M, Bloom SR. Pancreastatin distribution and plasma levels in the pig. Peptides 1988; 9: 1005–14
- Schmidt W E, Siegel E G, Lamberts R, Gallwitz B, Creutzfeld W. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988; 123: 1395–1404
- Kar S, Bretherton-Watt D, Gibson S J, Steel J H, Gentleman S M, Roberts G W, Valentino K, Tatemoto K, Ghatei M A, Bloom S R, Polak JM. Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. J Comp Neurol 1989; 268: 627–39
- Morris BJ. Specific radioactivity of radioimmunoassay tracer determined by self-displacement: a re-evaluation. Clin Chim Acta 1976; 73: 213–6
- Ekins R P, Newman GB. The theorectical aspects of saturation analysis. Acta Endocrinol 1970; 147: 11–30, suppl
- De Muckadell Schaffalitzky O B, Fahrenkrug J. Preparation of 125I-labelled synthetic porcine secretin for radioimmunoassay. Scand J Clin Lab Invest 1976; 36: 661–8
- Børglum Jensen T D, Fahrenkrug J, Sundler F. Immunocytochemical localization of pancreastatin and chromogranin A in porcine neuroendocrine tissues. Regul Pept 1991, in press
- Curry W J, Johnston C F, Shaw C, Buchanan KD. Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul Pept 1990; 30: 207–19
- O'Connor D T, Frigon R P, Sokoloff RL. Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma. Hypertension 1984; 6: 2–12
- Fischer-Colbrie R, Frischenschlager I. Immunological characterization of secretory proteins of chromaffin enkephalin-containing peptides. J Neurochem 1985; 44: 1854–61
- Fischer-Colbrie R, Schober M. Isolation and characterization of chromogranin A, B, and C from bovine chromaffin granules and a rat pheochromocytoma. J Neurochem 1987; 48: 262–70
- Simon J P, Bader M F, Aunis D. Secretion from chromaffin cells is controlled by chromogranin A-derived peptides. Proc Natl Acad Sci USA 1988; 85: 1712–6
- Simon J P, Aunis D. Biochemistry of the chromogranin A protein family. Biochem J 1989; 262: 1–13
- Kiang W L, Kursius T, Finne J, Margolis R U, Margolis RK. Glycoproteins and proteoglycans of the chromaffin granule matrix. J Biol Chem 1982; 257: 1651–9
- Apps D J, Phillips J H, Purves FC. Glycoproteins of the chromaffin granule matrix: use of lectin blotting to distinguish several separate classes. Neuro-science 1985; 16: 477–85